Abstract
Continuous glucose monitoring (CGM) technology can continuously monitor the glucose concentration in subcutaneous interstitial fluid through a glucose sensor, providing a glycemic profile throughout the day. CGM is able to detect occult hyperglycemia and hypoglycemia that cannot easily be detected by traditional glucose monitoring methods. In addition, CGM facilitates the understanding of the influence of diet, exercise, drugs, and other factors on blood glucose, prompting patients to establish a healthy lifestyle and improve patients’ adherence. Therefore, it plays an irreplaceable role in glucose monitoring for diabetes patients. Since CGM system detects glucose concentration through glucose sensors, the development of CGM is largely dependent on the evolution of glucose sensors. In 1999, MiniMed Inc. introduced the world’s first subcutaneously implanted glucose sensor and since then has initiated the clinical application of CGM. This chapter will discuss the development of CGM and the technical characteristics of common CGM equipment on the market.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Chinese Diabetes Society. Chinese clinical guideline for continuous glucose monitoring (2012). Chin J Diabetes Mellitus. 2012;4:582–90. https://doi.org/10.3760/cma.j.issn.1674-5809.2012.10.003.
Clark LC Jr, Lyons C. Electrode systems for continuous monitoring in cardiovascular surgery. Ann N Y Acad Sci. 1962;102:29–45.
Bankar SB, Bule MV, Singhal RS, Ananthanarayan L. Glucose oxidase–an overview. Biotechnol Adv. 2009;27:489–501. https://doi.org/10.1016/j.biotechadv.2009.04.003.
Heller A, Feldman B. Electrochemical glucose sensors and their applications in diabetes management. Chem Rev. 2008;108:2482–505. https://doi.org/10.1021/cr068069y.
Updike SJ, Hicks GP. The enzyme electrode. Nature. 1967;214:986–8.
Cass AE, Davis G, Francis GD, Hill HA, Aston WJ, Higgins IJ, Plotkin EV, Scott LD, Turner AP. Ferrocene-mediated enzyme electrode for amperometric determination of glucose. Anal Chem. 1984;56:667–71.
Matthews DR, Holman RR, Bown E, Steemson J, Watson A, Hughes S, Scott D. Pen-sized digital 30-second blood glucose meter. Lancet. 1987;1:778–9.
Palmisano F, Zambonin PG, Centonze D, Quinto M. A disposable, reagentless, third-generation glucose biosensor based on overoxidized poly (pyrrole) /tetrathiafulvalene–tetracyanoquinodimethane composite. Anal Chem. 2002;74:5913–8.
Albisser AM, Leibel BS, Ewart TG, Davidovac Z, Botz CK, Zingg W, Schipper H, Gander R. Clinical control of diabetes by the artificial pancreas. Diabetes. 1974;23:397–404.
Shichiri M, Kawamori R, Yamasaki Y, Hakui N, Abe H. Wearable artificial endocrine pancreas with needle-type glucose sensor. Lancet. 1982;2:1129–31.
Liu XF, Liu C. Comparison of several common continuous glucose monitoring systems. Int J Endocrinol Metab. 2009;29:197–200. https://doi.org/10.3760/cma.j.issn.1673-4157.2009.03.015.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd. and Shanghai Scientific and Technical Publishers
About this chapter
Cite this chapter
Lu, J.Y., Bao, Y. (2018). Introduction of Continuous Glucose Monitoring Technology. In: Jia, W. (eds) Continuous Glucose Monitoring. Springer, Singapore. https://doi.org/10.1007/978-981-10-7074-7_2
Download citation
DOI: https://doi.org/10.1007/978-981-10-7074-7_2
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-7073-0
Online ISBN: 978-981-10-7074-7
eBook Packages: MedicineMedicine (R0)